Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Shionogi & Co. presents new endothelial lipase inhibitors

July 20, 2011

Laboratoires Takeda withdraws pioglitazone-containing products from French market

July 18, 2011

Novo Nordisk discloses novel glucagon GLP-1 receptor agonists

July 18, 2011

Evolva completes phase I studies of EV-077

July 15, 2011

New glucokinase activators patented by Astellas Pharma

July 13, 2011

Universitat de Barcelona and CSIC present new glucosylceramidase inhibitors

July 13, 2011

Alnylam files CTA in U.K. for RNAi therapeutic ALN-PCS in severe hypercholesterolemia

July 13, 2011

Genfit reports encouraging phase II data on GFT-505 in diabetes

July 12, 2011

Alkermes discontinues development of ALKS-33 in binge eating disorder based on phase II data

July 11, 2011

Amarin completes nonclinical studies for AMR-101 NDA

July 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...